Treatment of hepatitis‐associated aplastic anemia with high‐dose cyclophosphamide

Publisher： John Wiley & Sons Inc

E-ISSN： 1545-5017|49|7|947-951

ISSN： 1545-5009

Source： PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.49, Iss.7, 2007-12, pp. : 947-951

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Epstein-Barr Virus-Associated Leukemic Lymphoma in a Patient Treated with Rabbit Antithymocyte Globulin and Cyclosporine for Hepatitis-Associated Aplastic Anemia

By  

Acta Haematologica, Vol. 127, Iss. 2, 2011-12 ,pp. : 96-99

Karger

Access to resources Recommend Favorite

Iatrogenesis or Bad Luck? Relapse of an LMP1-Positive Follicular Lymphoma after Immunosuppression for Hepatitis-Associated Aplastic Anaemia

By  

Acta Haematologica, Vol. 108, Iss. 2, 2002-08 ,pp. : 90-93

Karger

Access to resources Recommend Favorite

High-Dose Cyclophosphamide Therapy Associated with Diffuse Alveolar Hemorrhage after Allogeneic Hematopoietic Stem Cell Transplantation

By  

Respiration, Vol. 86, Iss. 6, 2012-12 ,pp. : 453-461

Karger

Access to resources Recommend Favorite

Twice-Weekly High-Dose rHuEpo for the Treatment of Anemia in Patients with Low-Risk Myelodysplastic Syndromes

By  

Acta Haematologica, Vol. 120, Iss. 2, 2008-10 ,pp. : 104-107

Karger

Access to resources Recommend Favorite

Successful Treatment of Epstein-Barr Virus-Associated Lymphoproliferative Disorder with Rituximab in a Patient Undergoing Immunosuppressive Therapy for Aplastic Anemia

By  

Acta Haematologica, Vol. 136, Iss. 3, 2016-08 ,pp. : 174-177

Karger

Access to resources Recommend Favorite